Salta al menu principale di navigazione Salta al contenuto principale Salta al piè di pagina del sito
FrancoAngeli Journals

Sezione Generale - Linee guida per i disturbi sintomatici

N. 54 (2024)

Linee guida NICE sulla psicoterapia cognitivocomportamentale nel trattamento delle psicosi e della schizofrenia negli adulti

DOI
https://doi.org/10.3280/qpc54-2024oa18654
Inviata
10 ottobre 2024
Pubblicato
17-10-2024

Abstract

Il presente elaborato è stato scritto sulla base della “National Institute of Health and Clinical Excellence (NICE) Guideline on Treatment and Management of Psychosis and Schizophrenia in Adults” (edizione del 2014, aggiornata fino al 2020 nel formato online), della quale rappresenta una fedele sintesi delle parti dedicate al ruolo della psicoterapia nel trattamento delle psicosi e della schizofrenia, con particolare riferimento alla psicoterapia cognitivo-comportamentale.

Riferimenti bibliografici

  1. Barrowclough C., Haddock G., Tarrier N., Lewis S.W., Moring J., O’Brien R., Schofield N. & McGovern J. (2001). Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders. The American Journal of Psychiatry, 158(10): 1706-1713. DOI: 10.1176/appi.ajp.158.10.1706.
  2. Beck A.T. (1979). Cognitive Therapy and the Emotional Disorders. New York: International Universities Press [trad. it.: Principi di terapia cognitiva. Milano: Astrolabio, 1984].
  3. British Psychological Society (2007). New Ways of Working for Applied Psychologists in Health and Social Care. The End of the Beginning. Leicester: British Psychological Society.
  4. Department of Health. National Service Framework for Mental Health Services (1999). Modern Standards and Service Models. London: Department of Health. www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_4009598.
  5. Durham R.C., Guthrie M., Morton R.V., Reid D.A., Treliving L.R., Fowler D. & Macdonald R.R. (2003). Tayside-Fife clinical trial of cognitive-behavioural therapy for medication-resistant psychotic symptoms. Results to 3-month follow-up. The British Journal of Psychiatry, 182: 303-311. DOI: 10.1192/bjp.182.4.303.
  6. Frith C.D. (1992). The Cognitive Neuropsychology of Schizophrenia. Hillsdale: Lawrence Erlbaum [trad. it.: Neuropsicologia cognitiva della schizofrenia. Milano: Raffaello Cortina Editore, 1995].
  7. Garety P.A, Hemsley D.R. (1994). Delusions: Investigations into the Psychology of Delusional Reasoning. Hove: Psychology Press.
  8. Garety P.A., Fowler D.G., Freeman D., Bebbington P., Dunn G. & Kuipers E. (2008). Cognitive-behavioural therapy and family intervention for relapse prevention and symptom reduction in psychosis: randomised controlled trial. The British Journal of Psychiatry, 192(6): 412-423. DOI: 10.1192/bjp.bp.107.043570.
  9. Jackson H., McGorry P., Edwards J., Hulbert C., Henry L., Harrigan S., Dudgeon P., Francey S., Maude D., Cocks J., Killackey E. & Power P. (2005). A controlled trial of cognitively oriented psychotherapy for early psychosis (COPE) with four-year follow-up readmission data. Psychological Medicine, 35(9): 1295-1306. DOI: 10.1017/S0033291705004927.
  10. Jackson H.J., McGorry P.D., Killackey E., Bendall S., Allott K., Dudgeon P., Gleeson J., Johnson T. & Harrigan S. (2008). Acute-phase and 1-year follow-up results of a randomized controlled trial of CBT versus Befriending for first-episode psychosis: the ACE project. Psychological Medicine, 38(5): 725-735. DOI: 10.1017/S0033291707002061.
  11. National Institute of Health and Clinical Excellence (2014). The NICE Guideline on Treatment and Management. London: National Collaborating Centre for Mental Health.
  12. Nuechterlein K.H. (1987). Vulnerability models for schizophrenia: state of the art. In: Hafner H., Gattaz W.F., Janzarik W. (eds.), Search for the Causes of Schizophrenia (pp. 297-316), Heidelberg: Springer.
  13. Rector N.A., Seeman M.V. & Segal Z.V. (2003). Cognitive therapy for schizophrenia: a preliminary randomized controlled trial. Schizophrenia Research, 63(1-2): 1-11. DOI: 10.1016/s0920-9964(02)00308-0.
  14. Roth A., Fonagy P. & Parry G. (1996). What Works for Whom? A Critical Review of Psychotherapy Research. New York: Guilford Press.
  15. Slade P.D., Bentall R.P. (1988). Sensory Deception: A Scientific Analysis of Hallucination. London: Croom Helm.
  16. Startup M., Jackson M.C. & Bendix S. (2004). North Wales randomized controlled trial of cognitive behaviour therapy for acute schizophrenia spectrum disorders: outcomes at 6 and 12 months. Psychological Medicine, 34(3): 413-422. DOI: 10.1017/s0033291703001211.
  17. Tarrier N., Beckett R., Harwood S., Baker A., Yusupoff L. & Ugarteburu I. (1993). A trial of two cognitive-behavioural methods of treating drug-resistant residual psychotic symptoms in schizophrenic patients: I. Outcome. The British Journal of Psychiatry, 162: 524-532. DOI: 10.1192/bjp.162.4.524.
  18. Trower P., Birchwood M., Meaden A., Byrne S., Nelson A. & Ross K. (2004). Cognitive therapy for command hallucinations: randomised controlled trial. The British Journal of Psychiatry, 184: 312-320. DOI: 10.1192/bjp.184.4.312.
  19. Turkington D., Kingdon D., Turner T. & Insight into Schizophrenia Research Group (2002). Effectiveness of a brief cognitive-behavioural therapy intervention in the treatment of schizophrenia. The British Journal of Psychiatry, 180: 523-527. DOI: 10.1192/bjp.180.6.523.
  20. Zubin J. & Spring B. (1977). Vulnerability-a new view of schizophrenia. Journal of Abnormal Psychology, 86(2): 103-126. DOI: 10.1037//0021-843x.86.2.103.

Metriche

Caricamento metriche ...